Literature DB >> 29615402

Screening Tool for Gynecologic Cancers Assessed.

.   

Abstract

Researchers have developed a test called PapSEEK that detects endometrial and ovarian cancers by analyzing DNA samples for mutations and aberrations in chromosome number. In a large, retrospective study, the test detected 81% of endometrial cancers and 33% of ovarian cancers with a low false-positive rate. ©2018 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2018        PMID: 29615402     DOI: 10.1158/2159-8290.CD-NB2018-038

Source DB:  PubMed          Journal:  Cancer Discov        ISSN: 2159-8274            Impact factor:   39.397


  1 in total

Review 1.  Contemporary Fertility-Sparing Management Options of Early Stage Endometrioid Endometrial Cancer in Young Nulliparous Patients.

Authors:  Gulzhanat Aimagambetova; Sanja Terzic; Antonio Simone Laganà; Gauri Bapayeva; Philip la Fleur; Milan Terzic
Journal:  J Clin Med       Date:  2021-12-30       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.